/PRNewswire/ -- In releasing a new report on maternal health nationwide, Amnesty International today revealed that flaws and shocking disparities in maternal health care that the government is ignoring lead to two to three women dying daily in the United States from pregnancy-related complications, with half of these deaths believed preventable, according to the Centers for Disease Control. A state-by-state examination shows that Georgia is 50th on a maternal mortality ranking, with 20.5 deaths per 100,000 live births.*
The new Amnesty International report, Deadly Delivery: The Maternal Health Care Crisis in the USA, also reveals that severe pregnancy-related complications that nearly cause death -- known as "near misses" -- are rising at an alarming rate, increasing by 25 percent since 1998; currently nearly 34,000 women annually experience a "near miss" during delivery. With a lifetime risk of maternal deaths that is greater than in 40 other countries, including virtually all of the industrialized countries, the United States has failed to reverse the two-decade upward trend in preventable maternal deaths, despite pledges to do so.
The report cited numerous causes for the crisis and offers lengthy recommendations on improving maternal health care.
Inadequate prenatal care is cited as a contributing factor in the crisis; women who do not get prenatal care are three to four times more likely to die than women who do. In Georgia, almost one in six women (15.8 percent) receive delayed or no prenatal care. The number rises to one in five women (21.9 percent) among women of color.
Obstacles to care are widespread: the most obvious being that across the United States nearly 13 million women of reproductive age (15 to 44), or one in five, have no health insurance. In Georgia nearly one in five women (19.7 percent) are uninsured; among women of color the number of uninsured climbs to 27.6 percent. The state's Medicaid eligibility level for working parents is also very low, $9,072. Lack of access to health care centers and providers is a problem nationwide, the report found; in Georgia 41 percent of women live in medically underserved areas.
"No issue can be more central to the health and well-being of our nation than maternal health care," said Jared Feuer, Southern Regional Director for Amnesty International USA. "The government should accept its duty and its moral obligation to address this inexcusable crisis by developing a comprehensive plan to ensure quality health care for all pregnant women. If the federal government can address steroid use in baseball, certainly lawmakers can address maternal health, which affects every family in the United States."
Maternal health is a human right for every woman in the United States, regardless of race or income. Yet, the United States lacks a systematic, robust government response to this critical problem. Amnesty International is urging President Obama to work with Health and Human Services Secretary Kathleen Sebelius to establish, and seek Congressional funding, for a single office responsible for ensuring that all women receive quality maternal health care. An Office of Maternal Health would lead government action to reduce the soaring pregnancy-related complications and maternal deaths nationwide.
Additionally, Amnesty International calls for vigorous enforcement of federal non-discrimination laws and an increase in support for Federally Qualified Health Centers by 2011 to expand the number of women who can access affordable maternal health care.
"This country's extraordinary record of medical advancement makes its haphazard approach to maternal care all the more scandalous and disgraceful," said Larry Cox, executive director of Amnesty International USA. "Mothers die not because the United States can't provide good care, but because it lacks the political will to make sure good care is available to all women."
Amnesty International's analysis shows that health care reform before Congress does not address the crisis of maternal health care.
"Reform is primarily focused on health care coverage and reducing health care costs, and even optimistic estimates predict that any proposal on the table will still leave millions without access to affordable care," said Rachel Ward, one of the authors of the Deadly Delivery report. "Furthermore, it does not address discrimination, systemic failures and government accountability documented in Amnesty International's report."
Rapid and comprehensive federal leadership is required, as the report found numerous systemic failures, including the following:
-- Burdensome bureaucratic procedures in Medicaid enrollment
substantially delay access to vital prenatal care for pregnant women
seeking government-funded care. Twenty-one states do not offer
"presumptive eligibility" which allows pregnant women to temporarily
access medical care while their permanent application for Medicaid is
pending. Women who do not receive any prenatal care are three to four
times more likely to die than women who do.
-- The number of deaths is significantly understated because there are no
federal requirements to report maternal deaths or complications and
data collection at the state level is insufficient.
-- Oversight and accountability is lacking. 29 states and the District of
Columbia have no maternal death review process at all.
Amnesty International is a Nobel Peace Prize-winning grassroots activist organization with more than 2.2 million supporters, activists and volunteers in more than 150 countries campaigning for human rights worldwide. The organization investigates and exposes abuses, educates and mobilizes the public, and works to protect people wherever justice, freedom, truth and dignity are denied.
For more information or to take action, please visit: www.amnestyusa.org/deadlydelivery
*National Women's Law Center, National Report Card on Women's Health, Maternal Mortality Rate Table; available at
http://hrc.nwlc.org/Status-Indicators/Key-Conditions/Maternal-Mortality-Ra te.aspx.
-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page
Follow us on Twitter: @GAFrontPage
Friday, March 12, 2010
New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Georgia is 50th Among All States in Maternal Mortality
Posted by
Georgia Front Page.com
at
9:50 AM
0
comments
Labels: complications, dying, fayette, fayette front page, fayetteville, georgia, georgia front page, health, maternal, peachtree city, pregnancy, report, tyrone
Monday, August 17, 2009
Mother's Immune System May Block Fetal Treatments for Blood Diseases
/PRNewswire/ -- Pediatric researchers have resolved an apparent contradiction in the field of prenatal cell transplantation -- a medical approach that holds future promise in correcting sickle cell disease and other serious congenital blood disorders. In a new study in animals, the researchers showed that the mother's immune response interferes with the offspring's earlier ability to tolerate transplanted donor cells.
The study team concludes that focusing on transplant techniques that avoid the maternal immune response may allow scientists to take advantage of fetal tolerance to achieve a long-sought goal of treating blood diseases prenatally.
While cautioning that much work must be done to understand how these animal findings apply to humans, the current findings are "surprising but reassuring," said study leader Alan W. Flake, M.D., of the Children's Center for Clinical Research at The Children's Hospital of Philadelphia.
The study appeared online August 3 in the Journal of Clinical Investigation.
For over 50 years, explained Flake, it has been a fundamental precept of immunology that a fetus tolerates foreign antigens in a window-of-opportunity period before its immune system fully develops the capacity to mount an immune response. Scientists assumed that by carefully introducing donor cells and stimulating a fetus to develop tolerance to those cells, one could set the stage for a later organ or cellular transplant that would not be rejected by a more mature immune system.
As prenatal diagnosis has continued to become available for a greater number of congenital diseases, scientists have considered the possibility of correcting blood disorders such as sickle cell disease or thalassemia. After first transplanting a small number of healthy cells in an early-stage fetus to establish tolerance, a second dose of transplanted cells later in gestation would proliferate, and treat the blood disorder before birth. Researchers use hematopoietic cells -- stem cells that that develop into blood cells -- in this technique, in utero hematopoietic cell transplantation (IUHCT).
However, over the years, Flake's team and other research groups found that IUHCT studies in animal models yielded inconsistent results, ranging from no tolerance to transplants to full tolerance and every degree of tolerance in between. Contrary to the concept of fetal tolerance, an immune barrier seemed to be acting against transplanted cells.
The current study, done in mice, solves the puzzle of an apparent immune barrier. Newborn mice (pups) that received cell transplants in utero were divided into two groups. Mice nursed by their biological mothers lost the transplanted donor cells, while mice nursed by foster mothers retained those donor cells.
The mothers whose fetuses received the donor cells transplants had developed antibodies against those cells, and subsequently transmitted those antibodies to their pups through breast milk. "Those antibodies in the breast milk triggered rejection of the transplanted blood cells in the pups," said Flake. "But in the absence of a maternal immune response, we confirmed that immune tolerance does occur in the early-gestation fetus 100 percent of the time."
Of course, mouse biology is not the same as human biology, and Flake added, "Mouse time is not the same as human time." Because mice have such a brief gestational period, the mother's immune response didn't develop until after the birth of her pups, and was therefore transferred by breastfeeding. In large animals and humans, said Flake, the more likely route of maternal-to-fetal transmission would be through the placenta late in pregnancy, and not through postnatal breastfeeding.
However, it remains an open question whether the mouse findings are applicable to larger mammals and especially to humans. Flake's study team is continuing their investigations in larger animal models.
Looking forward to techniques to avoid maternal immune reactions to prenatal cell transplants, Flake proposed two possibilities. One would be use the mother as a source of donor cells, which would not stimulate an unwanted immune response. Another strategy could involve inducing the generation of increased numbers of T regulatory cells; those cells normally act to prevent the fetus from inappropriately reacting against maternal cells.
The ultimate goal, said Flake, is to develop IUHCT as a prenatal treatment for any congenital blood disorder that may currently be treated with postnatal bone marrow transplants. That would include sickle cell disease, thalassemia, and some inherited immunodeficiency diseases. Currently such postnatal transplants are risky and relatively rare.
"Our current finding is not a clinical breakthrough," added Flake. "But it does offer new potential to the field of cellular transplantation."
Funds from the National Institutes of Health, the Ruth and Tristram C. Colket Jr. Chair of Pediatric Surgery at The Children's Hospital of Philadelphia and the Albert M. Greenfield Foundation supported this study.
-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page
www.artsacrossgeorgia.com
Arts Across Georgia
Posted by
Georgia Front Page.com
at
12:34 PM
0
comments
Labels: blood disorders, breast milk, congenital, donor cells, fayette front page, fetus, georgia, georgia front page, immune system, maternal, pediatric, prenatal cell transplantation, research, study